NASAL POLYPS TREATMENT MARKET ANALYSIS

Nasal Polyps Treatment Market, by Drug Class, (Corticosteroids, (Nasal corticosteroids, Fluticasone, Budesonide, Mometasone, Triamcinolone, Others - Beclomethasone, Ciclesonide, etc.), Oral/Injectable Corticosteroids (Prednisone, Combination), Antibiotics, Antihistamines, Interleukin Inhibitors, (Dupilumab, Others (IL 10, IL 25 etc.)), Monoclonal Antibodies, (Mepolizumab, Omalizumab, Others), Others (Aspirin, anticholinergic agent and etc.)), by Route of Administration (Nasal, Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Aug 2022
Code : CMI2775
Pages :520
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Nasal Polyps Treatment Market Share – Restraints

Increasing side effects of the drugs used for the treatment of nasal polyps is expected to hamper growth of the global nasal polyps treatment market, over the forecast period. For instance, according to 2019 revised data of National Institute of Health, fluticasone is a corticosteroids nasal spray used for the treatment of nasal polyps. It works by blocking the discharge of definite natural substances that cause allergy indications. Use of fluticasone nasal spray cause side effects such as severe face pain, thick nasal discharge, fever, sore throat, chills, cough, and other signs of infection, whistling sound from the nose, hives, rash, itching, swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs. These issues may hamper growth of the global nasal polyps treatment market.

Nasal Polyps Treatment Market Report Snapshots